HEADER IMMUNE SYSTEM/PEPTIDE 23-MAY-05 2BSS
TITLE CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE
TITLE 2 IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN B-27
COMPND 3 ALPHA CHAIN;
COMPND 4 CHAIN: A;
COMPND 5 FRAGMENT: EXTRACELLULAR DOMAIN, RESIDUES, 25-300;
COMPND 6 SYNONYM: HLA-B2705;
COMPND 7 ENGINEERED: YES;
COMPND 8 MOL_ID: 2;
COMPND 9 MOLECULE: BETA-2-MICROGLOBULIN;
COMPND 10 CHAIN: B;
COMPND 11 FRAGMENT: IMMUNOGLOBULIN DOMAIN, RESIDUES 21-119;
COMPND 12 SYNONYM: HDCMA22P;
COMPND 13 ENGINEERED: YES;
COMPND 14 MOL_ID: 3;
COMPND 15 MOLECULE: HIV PEPTIDE;
COMPND 16 CHAIN: C
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BLR;
SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET-22B;
SOURCE 9 MOL_ID: 2;
SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 11 ORGANISM_COMMON: HUMAN;
SOURCE 12 ORGANISM_TAXID: 9606;
SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 15 EXPRESSION_SYSTEM_STRAIN: BLR;
SOURCE 16 EXPRESSION_SYSTEM_PLASMID: PET-22B;
SOURCE 17 MOL_ID: 3;
SOURCE 18 SYNTHETIC: YES;
SOURCE 19 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS;
SOURCE 20 ORGANISM_TAXID: 12721
KEYWDS IMMUNE SYSTEM/PEPTIDE, COMPLEX (ANTIGEN/PEPTIDE), IMMUNE
KEYWDS 2 SYSTEM, MHC (MAJOR HISTOCOMPATIBILITY COMPLEX), MHC
KEYWDS 3 HLA-B27, HUMAN EBV HIV, COMPLEX ANTIGEN PEPTIDE
EXPDTA X-RAY DIFFRACTION
AUTHOR G.B.E.STEWART-JONES,K.DI GLERIA,S.KOLLNBERGER,A.J.MCMICHAEL,
AUTHOR 2 E.Y.JONES,P.BOWNESS
REVDAT 2 24-FEB-09 2BSS 1 VERSN
REVDAT 1 24-MAY-05 2BSS 0
JRNL AUTH G.B.E.STEWART-JONES,K.DI GLERIA,S.KOLLNBERGER,
JRNL AUTH 2 A.J.MCMICHAEL,E.Y.JONES,P.BOWNESS
JRNL TITL CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF
JRNL TITL 2 THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO
JRNL TITL 3 HLA-B*2705
JRNL REF EUR.J.IMMUNOL. V. 35 341 2005
JRNL REFN ISSN 0014-2980
JRNL PMID 15657948
JRNL DOI 10.1002/EJI.200425724
REMARK 2
REMARK 2 RESOLUTION. 2.0 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.0
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20
REMARK 3 DATA CUTOFF (SIGMA(F)) : 2
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.2
REMARK 3 NUMBER OF REFLECTIONS : 33405
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : NULL
REMARK 3 R VALUE (WORKING SET) : 0.231
REMARK 3 FREE R VALUE : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL
REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : NULL
REMARK 3 BIN FREE R VALUE : NULL
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3177
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 0
REMARK 3 SOLVENT ATOMS : 183
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.006
REMARK 3 BOND ANGLES (DEGREES) : 1.3
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : NULL
REMARK 3 KSOL : NULL
REMARK 3 BSOL : NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 PARAMETER FILE 2 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 2 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 2BSS COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 24-MAY-05.
REMARK 100 THE PDBE ID CODE IS EBI-24191.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 25-NOV-03
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : 6.50
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ESRF
REMARK 200 BEAMLINE : ID14-1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.934
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : NULL
REMARK 200 DETECTOR MANUFACTURER : NULL
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33405
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000
REMARK 200 RESOLUTION RANGE LOW (A) : 20.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.900
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2
REMARK 200 DATA REDUNDANCY : 15.000
REMARK 200 R MERGE (I) : 0.08000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): NULL
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA):NULL
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.65000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.25000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.20000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.25000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.65000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.20000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 GENERATING THE BIOMOLECULE
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC
REMARK 350 SOFTWARE USED: PQS
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 29 -122.57 54.85
REMARK 500 PRO A 43 116.01 -33.84
REMARK 500 HIS A 114 104.44 -168.93
REMARK 500 GLN A 224 35.73 -88.63
REMARK 500 ARG A 239 -22.25 90.40
REMARK 500 LYS B 48 76.36 52.82
REMARK 500 TRP B 60 -4.96 74.03
REMARK 500 ARG B 97 46.13 -64.13
REMARK 500 ASP B 98 15.13 -159.02
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 700
REMARK 700 SHEET
REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN
REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW,
REMARK 700 TWO SHEETS ARE DEFINED.
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1A1M RELATED DB: PDB
REMARK 900 MHC CLASS I MOLECULE B*5301 COMPLEXED WITH
REMARK 900 PEPTIDETYPDINQML FROM GAG PROTEIN OF HIV2
REMARK 900 RELATED ID: 1A1N RELATED DB: PDB
REMARK 900 MHC CLASS I MOLECULE B*3501 COMPLEXED WITH
REMARK 900 PEPTIDE VPLRPMTYFROM THE NEF PROTEIN (75-
REMARK 900 82) OF HIV1
REMARK 900 RELATED ID: 1A1O RELATED DB: PDB
REMARK 900 MHC CLASS I MOLECULE B5301 COMPLEXED WITH
REMARK 900 PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA
REMARK 900 PARASITE P. FALCIPARUM
REMARK 900 RELATED ID: 1A6Z RELATED DB: PDB
REMARK 900 HFE (HUMAN) HEMOCHROMATOSIS PROTEIN
REMARK 900 RELATED ID: 1A9B RELATED DB: PDB
REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE
REMARK 900 BOUND TO HLA-B 3501 DUE TO NONSTANDARD
REMARK 900 POSITIONING OF THE C-TERMINUS
REMARK 900 RELATED ID: 1A9E RELATED DB: PDB
REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE
REMARK 900 BOUND TO HLA-B 3501 DUE TO NONSTANDARD
REMARK 900 POSITIONING OF THE C-TERMINUS
REMARK 900 RELATED ID: 1AGB RELATED DB: PDB
REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE
REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG
REMARK 900 PEPTIDE (GGRKKYKL - 3R MUTATION)
REMARK 900 RELATED ID: 1AGC RELATED DB: PDB
REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE
REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG
REMARK 900 PEPTIDE (GGKKKYQL - 7Q MUTATION)
REMARK 900 RELATED ID: 1AGD RELATED DB: PDB
REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE
REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG
REMARK 900 PEPTIDE (GGKKKYKL - INDEX PEPTIDE)
REMARK 900 RELATED ID: 1AGE RELATED DB: PDB
REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE
REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG
REMARK 900 PEPTIDE (GGKKKYRL - 7R MUTATION)
REMARK 900 RELATED ID: 1AGF RELATED DB: PDB
REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE
REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG
REMARK 900 PEPTIDE (GGKKRYKL - 5R MUTATION)
REMARK 900 RELATED ID: 1AKJ RELATED DB: PDB
REMARK 900 COMPLEX OF THE HUMAN MHC CLASS I
REMARK 900 GLYCOPROTEIN HLA-A2 ANDTHE T CELL CORECEPTOR
REMARK 900 CD8
REMARK 900 RELATED ID: 1AO7 RELATED DB: PDB
REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL
REMARK 900 PEPTIDE (TAX), AND HLA-A 0201
REMARK 900 RELATED ID: 1B0G RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (
REMARK 900 HLA-A2.1) COMPLEXED WITH BETA 2-
REMARK 900 MICROGLOBULIN AND HUMAN PEPTIDE P1049
REMARK 900 RELATED ID: 1B0R RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED
REMARK 900 WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL
REMARK 900 GROUP SUBSTITUTED BY A METHYL GROUP
REMARK 900 RELATED ID: 1BD2 RELATED DB: PDB
REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7,
REMARK 900 VIRAL PEPTIDE (TAX) AND MHC CLASS I
REMARK 900 MOLECULE HLA-A 0201
REMARK 900 RELATED ID: 1C16 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/
REMARK 900 DELTA T CELL LIGAND T22
REMARK 900 RELATED ID: 1CE6 RELATED DB: PDB
REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH A
REMARK 900 SENDAI VIRUSNUCLEOPROTEIN PEPTIDE
REMARK 900 RELATED ID: 1CG9 RELATED DB: PDB
REMARK 900 COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-
REMARK 900 DETERMINANT ONHLA-B AND-C MOLECULES BY THE
REMARK 900 MONOCLONAL ANTIBODY SFR8-B6
REMARK 900 RELATED ID: 1DE4 RELATED DB: PDB
REMARK 900 HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH
REMARK 900 TRANSFERRINRECEPTOR
REMARK 900 RELATED ID: 1DUY RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX
REMARK 900 PEPTIDE COMPLEX
REMARK 900 RELATED ID: 1DUZ RELATED DB: PDB
REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA
REMARK 900 -A 0201) INCOMPLEX WITH A NONAMERIC PEPTIDE
REMARK 900 FROM HTLV-1 TAX PROTEIN
REMARK 900 RELATED ID: 1E27 RELATED DB: PDB
REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101
REMARK 900 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1
REMARK 900 (LPPVVAKEI)
REMARK 900 RELATED ID: 1E28 RELATED DB: PDB
REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101
REMARK 900 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2
REMARK 900 (TAFTIPSI)
REMARK 900 RELATED ID: 1EEY RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA A2
REMARK 900 COMPLEXED TOPEPTIDE GP2 WITH THE SUBSTITUTION
REMARK 900 (I2L/V5L/L9V)
REMARK 900 RELATED ID: 1EEZ RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1
REMARK 900 COMPLEXED TOGP2 PEPTIDE VARIANT(I2L/V5L)
REMARK 900 RELATED ID: 1EFX RELATED DB: PDB
REMARK 900 STRUCTURE OF A COMPLEX BETWEEN THE HUMAN
REMARK 900 NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A
REMARK 900 CLASS I MHC LIGAND HLA-CW3
REMARK 900 RELATED ID: 1EXU RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED
REMARK 900 FC RECEPTOR
REMARK 900 RELATED ID: 1GZP RELATED DB: PDB
REMARK 900 CD1B IN COMPLEX WITH GM2 GANGLIOSIDE
REMARK 900 RELATED ID: 1GZQ RELATED DB: PDB
REMARK 900 CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL
REMARK 900 RELATED ID: 1HHG RELATED DB: PDB
REMARK 900
REMARK 900 RELATED ID: 1HHH RELATED DB: PDB
REMARK 900
REMARK 900 RELATED ID: 1HHI RELATED DB: PDB
REMARK 900
REMARK 900 RELATED ID: 1HHJ RELATED DB: PDB
REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA
REMARK 900 -A 0201) COMPLEX WITH A NONAMERIC PEPTIDE
REMARK 900 FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES
REMARK 900 309-317)
REMARK 900 RELATED ID: 1HHK RELATED DB: PDB
REMARK 900
REMARK 900 RELATED ID: 1HLA RELATED DB: PDB
REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 (
REMARK 900 HLA-A2, HUMAN LEUCOCYTE ANTIGEN)
REMARK 900 RELATED ID: 1HSA RELATED DB: PDB
REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-
REMARK 900 B(ASTERISK)2705
REMARK 900 RELATED ID: 1HSB RELATED DB: PDB
REMARK 900 CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 (
REMARK 900 LEUCOCYTE ANTIGEN)
REMARK 900 RELATED ID: 1I1F RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (
REMARK 900 HLA-A2.1) COMPLEXED WITH BETA 2-
REMARK 900 MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
REMARK 900 RELATED ID: 1I1Y RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (
REMARK 900 HLA-A2.1) COMPLEXED WITH BETA 2-
REMARK 900 MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y
REMARK 900 RELATED ID: 1I4F RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4-
REMARK 900 PEPTIDE COMPLEX
REMARK 900 RELATED ID: 1I7R RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN
REMARK 900 COMPLEX WITH PEPTIDEP1058
REMARK 900 RELATED ID: 1I7T RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN
REMARK 900 COMPLEX WITH PEPTIDEP1049-5V
REMARK 900 RELATED ID: 1I7U RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN
REMARK 900 COMPLEX WITH PEPTIDEP1049-6V
REMARK 900 RELATED ID: 1IM3 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS
REMARK 900 PROTEIN US2BOUND TO THE MHC CLASS I
REMARK 900 MOLECULE HLA-A2/TAX
REMARK 900 RELATED ID: 1IM9 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN NATURAL
REMARK 900 KILLER CELLINHIBITORY RECEPTOR KIR2DL1 BOUND
REMARK 900 TO ITS MHC LIGAND HLA-CW4
REMARK 900 RELATED ID: 1JF1 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN
REMARK 900 COMPLEX WITH ADECAMERIC ALTERED PEPTIDE LIGAND
REMARK 900 FROM THE MART-1/MELAN-A
REMARK 900 RELATED ID: 1JGD RELATED DB: PDB
REMARK 900 HLA-B*2709 BOUND TO DECA-PEPTIDE S10R
REMARK 900 RELATED ID: 1JGE RELATED DB: PDB
REMARK 900 HLA-B*2705 BOUND TO NONA-PEPTIDE M9
REMARK 900 RELATED ID: 1JHT RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN
REMARK 900 COMPLEX WITH ANONAMERIC ALTERED PEPTIDE LIGAND
REMARK 900 (ALGIGILTV) FROM THE MART-1/MELAN-A.
REMARK 900 RELATED ID: 1JNJ RELATED DB: PDB
REMARK 900 NMR SOLUTION STRUCTURE OF THE HUMAN BETA2-
REMARK 900 MICROGLOBULIN
REMARK 900 RELATED ID: 1K5N RELATED DB: PDB
REMARK 900 HLA-B*2709 BOUND TO NONA-PEPTIDE M9
REMARK 900 RELATED ID: 1KPR RELATED DB: PDB
REMARK 900 THE HUMAN NON-CLASSICAL MAJOR
REMARK 900 HISTOCOMPATIBILITY COMPLEXMOLECULE HLA-E
REMARK 900 RELATED ID: 1KTL RELATED DB: PDB
REMARK 900 THE HUMAN NON-CLASSICAL MAJOR
REMARK 900 HISTOCOMPATIBILITY COMPLEXMOLECULE HLA-E
REMARK 900 RELATED ID: 1LDS RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2
REMARK 900 -MICROGLOBULIN
REMARK 900 RELATED ID: 1LP9 RELATED DB: PDB
REMARK 900 XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND
REMARK 900 TO P1049/HLA-A2.1
REMARK 900 RELATED ID: 1M05 RELATED DB: PDB
REMARK 900 HLA B8 IN COMPLEX WITH AN EPSTEIN BARR
REMARK 900 VIRUS DETERMINANT
REMARK 900 RELATED ID: 1M6O RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX
REMARK 900 WITH HLADPA*0201 PEPTIDE
REMARK 900 RELATED ID: 1MHE RELATED DB: PDB
REMARK 900 THE HUMAN NON-CLASSICAL MAJOR
REMARK 900 HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
REMARK 900 RELATED ID: 1MI5 RELATED DB: PDB
REMARK 900 THE CRYSTAL STRUCTURE OF LC13 TCR IN
REMARK 900 COMPLEX WITH HLAB8-EBVPEPTIDE COMPLEX
REMARK 900 RELATED ID: 1N2R RELATED DB: PDB
REMARK 900 A NATURAL SELECTED DIMORPHISM IN HLA B*44
REMARK 900 ALTERS SELF,PEPTIDE REPORTOIRE AND T CELL
REMARK 900 RECOGNITION.
REMARK 900 RELATED ID: 1OF2 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED
REMARK 900 WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE
REMARK 900 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400-408
REMARK 900 )
REMARK 900 RELATED ID: 1OGA RELATED DB: PDB
REMARK 900 A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN
REMARK 900 T-CELL RECEPTOR RECOGNITION.
REMARK 900 RELATED ID: 1OGT RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED
REMARK 900 WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE
REMARK 900 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400-408
REMARK 900 )
REMARK 900 RELATED ID: 1ONQ RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH
REMARK 900 A SULFATIDE
REMARK 900 RELATED ID: 1P7Q RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR-
REMARK 900 1, A HOST ANDVIRAL MHC RECEPTOR
REMARK 900 RELATED ID: 1PY4 RELATED DB: PDB
REMARK 900 BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS
REMARK 900 FOR AMYLOIDFORMATIONS
REMARK 900 RELATED ID: 1Q94 RELATED DB: PDB
REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH
REMARK 900 IMMUNODOMINANTNONAMER AND DECAMER HIV-1
REMARK 900 EPITOPES CLEARLY REVEAL THEPRESENCE OF A
REMARK 900 MIDDLE ANCHOR RESIDUE
REMARK 900 RELATED ID: 1QEW RELATED DB: PDB
REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA
REMARK 900 -A 0201)COMPLEX WITH A NONAMERIC PEPTIDE
REMARK 900 FROM MELANOMA-ASSOCIATEDANTIGEN 3 (RESIDUES
REMARK 900 271-279)
REMARK 900 RELATED ID: 1QLF RELATED DB: PDB
REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH
REMARK 900 GLYCOPEPTIDE K3G
REMARK 900 RELATED ID: 1QQD RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR
REMARK 900 THE KIR2D NATURAL KILLER CELL INHIBITORY
REMARK 900 RECEPTOR
REMARK 900 RELATED ID: 1QR1 RELATED DB: PDB
REMARK 900 POOR BINDING OF A HER-2/NEU EPITOPE (GP2
REMARK 900 ) TO HLA-A2.1 IS DUE TO A LACK OF
REMARK 900 INTERACTIONS IN THE CENTER OF THE PEPTIDE
REMARK 900 RELATED ID: 1QRN RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED
REMARK 900 WITH HLA-A2 BOUND TO ALTERED HTLV-1
REMARK 900 TAX PEPTIDE P6A
REMARK 900 RELATED ID: 1QSE RELATED DB: PDB
REMARK 900 STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-
REMARK 900 A2 COMPLEXED WITH ALTERED HTLV-1 TAX
REMARK 900 PEPTIDE V7R
REMARK 900 RELATED ID: 1QSF RELATED DB: PDB
REMARK 900 STRUCTURE OF A6-TCR BOUND TO HLA-A2
REMARK 900 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE
REMARK 900 Y8A
REMARK 900 RELATED ID: 1QVO RELATED DB: PDB
REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH
REMARK 900 IMMUNODOMINANTNONAMER AND DECAMER HIV-1
REMARK 900 EPITOPES CLEARLY REVEAL THEPRESENCE OF A
REMARK 900 MIDDLE ANCHOR RESIDUE
REMARK 900 RELATED ID: 1R3H RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF T10
REMARK 900 RELATED ID: 1S9W RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1
REMARK 900 EPITOPE, SLLMWITQC,IN COMPLEX WITH HLA-A2
REMARK 900 RELATED ID: 1S9X RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1
REMARK 900 EPITOPE ANALOGUE,SLLMWITQA, IN COMPLEX WITH
REMARK 900 HLA-A2
REMARK 900 RELATED ID: 1S9Y RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1
REMARK 900 EPITOPE ANALOGUE,SLLMWITQS, IN COMPLEX WITH
REMARK 900 HLA-A2
REMARK 900 RELATED ID: 1SYS RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA, B*4403, AND
REMARK 900 PEPTIDE EEPTVIKKY
REMARK 900 RELATED ID: 1SYV RELATED DB: PDB
REMARK 900 HLA-B*4405 COMPLEXED TO THE DOMINANT SELF
REMARK 900 LIGAND EEFGRAYGF
REMARK 900 RELATED ID: 1TMC RELATED DB: PDB
REMARK 900 TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY
REMARK 900 ANTIGEN HLA-AW68 COMPLEXED WITH A DECAMERIC
REMARK 900 PEPTIDE (EVAPPEYHRK)
REMARK 900 RELATED ID: 1TVB RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100(
REMARK 900 209-217) BOUNDTO HUMAN CLASS I MHC HLA-
REMARK 900 A2
REMARK 900 RELATED ID: 1TVH RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN
REMARK 900 GP100(209-T2M) BOUND TO HUMAN CLASS I
REMARK 900 MHC HLA-A2
REMARK 900 RELATED ID: 1UQS RELATED DB: PDB
REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A
REMARK 900 BOUND BACTERIAL GLYCOLIPID
REMARK 900 RELATED ID: 1UR7 RELATED DB: PDB
REMARK 900 MOLECULAR REFINEMENT OF ANTI-HLA-A2 USING
REMARK 900 LIGHT CHAIN SHUFFLING: A STRUCTURAL MODEL
REMARK 900 FOR HLA ANTIBODY BINDING
REMARK 900 RELATED ID: 1UXS RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED
REMARK 900 WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE
REMARK 900 (LMP2)OF EPSTEIN-BARR VIRUS
REMARK 900 RELATED ID: 1UXW RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED
REMARK 900 WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE
REMARK 900 (LMP2) OF EPSTEIN-BARR VIRUS
REMARK 900 RELATED ID: 1W0V RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED
REMARK 900 WITH THE SELF-PEPTIDE TIS FROM EGF-
REMARK 900 RESPONSE FACTOR 1
REMARK 900 RELATED ID: 1W0W RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED
REMARK 900 WITH THE SELF-PEPTIDE TIS FROM EGF-
REMARK 900 RESPONSE FACTOR 1
REMARK 900 RELATED ID: 1W72 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN
REMARK 900 COMPLEX WITH FAB-HYB3
REMARK 900 RELATED ID: 1XH3 RELATED DB: PDB
REMARK 900 CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF
REMARK 900 14-MERICPEPTIDES IN COMPLEX WITH HLA-B*
REMARK 900 3501
REMARK 900 RELATED ID: 1XR8 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN
REMARK 900 COMPLEX WITH PEPTIDESFROM HUMAN UBCH6 AND
REMARK 900 EPSTEIN-BARR VIRUS EBNA-3
REMARK 900 RELATED ID: 1XR9 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN
REMARK 900 COMPLEX WITH PEPTIDESFROM HUMAN UBCH6 AND
REMARK 900 EPSTEIN-BARR VIRUS EBNA-3
REMARK 900 RELATED ID: 1XZ0 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH
REMARK 900 A SYNTHETICMYCOBACTIN LIPOPEPTIDE
REMARK 900 RELATED ID: 1YDP RELATED DB: PDB
REMARK 900 1.9A CRYSTAL STRUCTURE OF HLA-G
REMARK 900 RELATED ID: 1YPZ RELATED DB: PDB
REMARK 900 IMMUNE RECEPTOR
REMARK 900 RELATED ID: 2BNQ RELATED DB: PDB
REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED
REMARK 900 IMMUNOGENICITY OF T CELL VACCINES
REMARK 900 RELATED ID: 2BNR RELATED DB: PDB
REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED
REMARK 900 IMMUNOGENICITY OF T CELL VACCINES
REMARK 900 RELATED ID: 2CLR RELATED DB: PDB
REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA
REMARK 900 -A 0201) COMPLEXED WITH A DECAMERIC PEPTIDE
REMARK 900 FROM CALRETICULIN
REMARK 900 RELATED ID: 2HLA RELATED DB: PDB
REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW
REMARK 900 68.1 (HLA-AW 68.1, HUMAN LEUCOCYTE
REMARK 900 ANTIGEN)
REMARK 900 RELATED ID: 3HLA RELATED DB: PDB
REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2.
REMARK 900 1 (HLA-A2.1 HUMAN LEUCOCYTE ANTIGEN)
REMARK 900 RELATED ID: 2BSR RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION
REMARK 900 OF THREE IMMUNODOMINANT VIRAL PEPTIDES
REMARK 900 COMPLEXED TO HLA-B2705
REMARK 900 RELATED ID: 2BST RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION
REMARK 900 OF THREE IMMUNODOMINANT VIRAL PEPTIDES
REMARK 900 COMPLEXED TO HLA-B2705
DBREF 2BSS A 1 276 UNP P03989 1B27_HUMAN 25 300
DBREF 2BSS B 0 0 PDB 2BSS 2BSS 0 0
DBREF 2BSS B 1 99 UNP P61769 B2MG_HUMAN 1 99
DBREF 2BSS C 1 10 PDB 2BSS 2BSS 1 10
SEQADV 2BSS ASN A 116 UNP P03989 ASP 140 CONFLICT
SEQRES 1 A 276 GLY SER HIS SER MET ARG TYR PHE HIS THR SER VAL SER
SEQRES 2 A 276 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE THR VAL GLY
SEQRES 3 A 276 TYR VAL ASP ASP THR LEU PHE VAL ARG PHE ASP SER ASP
SEQRES 4 A 276 ALA ALA SER PRO ARG GLU GLU PRO ARG ALA PRO TRP ILE
SEQRES 5 A 276 GLU GLN GLU GLY PRO GLU TYR TRP ASP ARG GLU THR GLN
SEQRES 6 A 276 ILE CYS LYS ALA LYS ALA GLN THR ASP ARG GLU ASP LEU
SEQRES 7 A 276 ARG THR LEU LEU ARG TYR TYR ASN GLN SER GLU ALA GLY
SEQRES 8 A 276 SER HIS THR LEU GLN ASN MET TYR GLY CYS ASP VAL GLY
SEQRES 9 A 276 PRO ASP GLY ARG LEU LEU ARG GLY TYR HIS GLN ASN ALA
SEQRES 10 A 276 TYR ASP GLY LYS ASP TYR ILE ALA LEU ASN GLU ASP LEU
SEQRES 11 A 276 SER SER TRP THR ALA ALA ASP THR ALA ALA GLN ILE THR
SEQRES 12 A 276 GLN ARG LYS TRP GLU ALA ALA ARG VAL ALA GLU GLN LEU
SEQRES 13 A 276 ARG ALA TYR LEU GLU GLY GLU CYS VAL GLU TRP LEU ARG
SEQRES 14 A 276 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG ALA
SEQRES 15 A 276 ASP PRO PRO LYS THR HIS VAL THR HIS HIS PRO ILE SER
SEQRES 16 A 276 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU GLY PHE
SEQRES 17 A 276 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY
SEQRES 18 A 276 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG
SEQRES 19 A 276 PRO ALA GLY ASP ARG THR PHE GLN LYS TRP ALA ALA VAL
SEQRES 20 A 276 VAL VAL PRO SER GLY GLU GLU GLN ARG TYR THR CYS HIS
SEQRES 21 A 276 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG
SEQRES 22 A 276 TRP GLU PRO
SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG
SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS
SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP
SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS
SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU
SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU
SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO
SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET
SEQRES 1 C 10 LYS ARG TRP ILE ILE LEU GLY LEU ASN LYS
FORMUL 4 HOH *183(H2 O1)
HELIX 1 1 ALA A 49 GLN A 54 1 6
HELIX 2 2 GLY A 56 TYR A 85 1 30
HELIX 3 3 ASP A 137 ALA A 150 1 14
HELIX 4 4 ARG A 151 GLY A 162 1 12
HELIX 5 5 GLY A 162 GLY A 175 1 14
HELIX 6 6 GLY A 175 GLN A 180 1 6
HELIX 7 7 THR A 225 THR A 228 5 4
HELIX 8 8 GLU A 253 GLN A 255 5 3
SHEET 1 AA 8 GLU A 46 PRO A 47 0
SHEET 2 AA 8 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46
SHEET 3 AA 8 ARG A 21 VAL A 28 -1 O THR A 24 N PHE A 36
SHEET 4 AA 8 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27
SHEET 5 AA 8 THR A 94 VAL A 103 -1 O LEU A 95 N SER A 11
SHEET 6 AA 8 LEU A 109 TYR A 118 -1 N LEU A 110 O ASP A 102
SHEET 7 AA 8 LYS A 121 LEU A 126 -1 O LYS A 121 N TYR A 118
SHEET 8 AA 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125
SHEET 1 AB 4 LYS A 186 PRO A 193 0
SHEET 2 AB 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192
SHEET 3 AB 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208
SHEET 4 AB 4 GLU A 229 LEU A 230 -1 O GLU A 229 N ALA A 246
SHEET 1 AC 4 LYS A 186 PRO A 193 0
SHEET 2 AC 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192
SHEET 3 AC 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208
SHEET 4 AC 4 ARG A 234 PRO A 235 -1 O ARG A 234 N GLN A 242
SHEET 1 AD 4 GLU A 222 ASP A 223 0
SHEET 2 AD 4 THR A 214 ARG A 219 -1 O ARG A 219 N GLU A 222
SHEET 3 AD 4 TYR A 257 GLN A 262 -1 O THR A 258 N GLN A 218
SHEET 4 AD 4 LEU A 270 LEU A 272 -1 O LEU A 270 N VAL A 261
SHEET 1 BA 4 LYS B 6 SER B 11 0
SHEET 2 BA 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10
SHEET 3 BA 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30
SHEET 4 BA 4 GLU B 50 HIS B 51 -1 O GLU B 50 N TYR B 67
SHEET 1 BB 4 LYS B 6 SER B 11 0
SHEET 2 BB 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10
SHEET 3 BB 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30
SHEET 4 BB 4 SER B 55 PHE B 56 -1 O SER B 55 N TYR B 63
SHEET 1 BC 4 GLU B 44 ARG B 45 0
SHEET 2 BC 4 GLU B 36 LYS B 41 -1 O LYS B 41 N GLU B 44
SHEET 3 BC 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40
SHEET 4 BC 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82
SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.05
SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.03
SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03
CISPEP 1 TYR A 209 PRO A 210 0 0.25
CISPEP 2 HIS B 31 PRO B 32 0 -0.07
CRYST1 51.300 82.400 108.500 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019475 0.000000 0.000000 0.00000
SCALE2 0.000000 0.012129 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009218 0.00000
(ATOM LINES ARE NOT SHOWN.)
END